Solid Biosciences (SLDB) Short Interest Ratio & Short Volume $5.60 -0.33 (-5.56%) Closing price 04:00 PM EasternExtended Trading$5.66 +0.06 (+0.98%) As of 06:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Solid Biosciences Short Interest DataSolid Biosciences (SLDB) has a short interest of 10.11 million shares, representing 17.88% of the float (the number of shares available for trading by the public). This marks a -1.17% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.0, indicating that it would take 6.0 days of the average trading volume of 1.90 million shares to cover all short positions.Current Short Interest10,110,000 sharesPrevious Short Interest10,230,000 sharesChange Vs. Previous Month-1.17%Dollar Volume Sold Short$69.15 millionShort Interest Ratio6.0 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares77,869,000 sharesFloat Size56,530,000 sharesShort Percent of Float17.88%Today's Trading Volume805,105 sharesAverage Trading Volume1,901,390 sharesToday's Volume Vs. Average42% Short Selling Solid Biosciences? Sign up to receive the latest short interest report for Solid Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSLDB Short Interest Over TimeSLDB Days to Cover Over TimeSLDB Percentage of Float Shorted Over Time Solid Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/202510,110,000 shares $69.15 million -1.2%17.9%6 $6.84 7/15/202510,230,000 shares $55.14 million +0.9%18.2%5.8 $5.39 6/30/202510,140,000 shares $49.38 million +25.5%18.0%5.9 $4.87 6/15/20258,080,000 shares $36.44 million -3.2%14.3%5.1 $4.51 5/31/20258,350,000 shares $26.72 million -7.7%14.8%5.4 $3.20 5/15/20259,050,000 shares $23.44 million +27.6%16.0%6.1 $2.59 4/30/20257,090,000 shares $23.47 million -12.0%11.0%2.6 $3.31 4/15/20258,060,000 shares $21.76 million -6.5%12.5%3.2 $2.70 3/31/20258,620,000 shares $31.89 million +10.0%12.9%3.6 $3.70 3/15/20257,840,000 shares $39.91 million +7.1%11.5%3.5 $5.09 Get the Latest News and Ratings for SLDB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Solid Biosciences and its competitors with MarketBeat's FREE daily newsletter. 2/28/20257,320,000 shares $40.92 million +148.1%12.3%3.4 $5.59 2/15/20252,950,000 shares $11.89 million +11.3%5.0%1.5 $4.03 1/31/20252,650,000 shares $8.43 million +13.7%8.1%5.2 $3.18 1/15/20252,330,000 shares $7.32 million +13.1%7.1%5.7 $3.14 12/31/20242,060,000 shares $8.24 million +17.1%6.3%5.3 $4.00 12/15/20241,760,000 shares $8.64 million +13.6%5.4%5.6 $4.91 11/30/20241,550,000 shares $8.84 million +2.0%4.8%5.3 $5.70 11/15/20241,520,000 shares $7.37 million +2.7%4.7%5.3 $4.85 10/31/20241,480,000 shares $8.17 million -16.4%4.4%5.5 $5.52 10/15/20241,770,000 shares $11.74 million +2.3%5.5%6.6 $6.63 9/30/20241,730,000 shares $12.06 million +4.2%5.3%6 $6.97 9/15/20241,660,000 shares $13.16 million -1.8%5.1%3.9 $7.93 8/31/20241,690,000 shares $15.09 million -2.3%5.2%3.6 $8.93 8/15/20241,730,000 shares $15.45 million +8.1%5.3%3.6 $8.93 7/31/20241,600,000 shares $14.27 million -3.6%5.0%3.6 $8.92 7/15/20241,660,000 shares $14.21 million -45.6%5.2%3.7 $8.56 6/30/20243,050,000 shares $17.29 million +237.4%9.6%7.8 $5.67 6/15/2024904,100 shares $7.14 million +7.6%2.8%3.1 $7.90 5/31/2024840,200 shares $6.94 million -9.6%2.7%3.4 $8.26 5/15/2024929,200 shares $9.00 million +1.7%3.0%3.8 $9.69 4/30/2024913,600 shares $8.10 million -13.0%3.0%3.6 $8.87 4/15/20241,050,000 shares $10.50 million +14.0%3.5%4 $10.00 3/31/2024920,900 shares $12.27 million +49.8%3.1%2.5 $13.32 3/15/2024614,900 shares $8.04 million -3.0%2.0%1.8 $13.08 2/29/2024633,600 shares $5.95 million +4.3%2.1%1.3 $9.39 2/15/2024607,300 shares $5.97 million +41.8%2.0%1.3 $9.83 1/31/2024428,300 shares $2.95 million +11.5%1.8%0.6 $6.89 1/15/2024384,000 shares $2.96 million +55.0%2.8%0.6 $7.71 12/31/2023247,800 shares $1.52 million +21.8%1.5%0.4 $6.14 12/15/2023203,400 shares $1.06 million -6.4%1.2%0.4 $5.19Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow 11/30/2023217,200 shares $612.50 thousand +508.4%1.3%0.5 $2.82 11/15/202335,700 shares $97.28 thousand -5.8%0.2%0.1 $2.73 10/31/202337,900 shares $84.52 thousand +76.3%0.2%1.4 $2.23 10/15/202321,500 shares $46.44 thousand -27.4%0.1%0.9 $2.16 9/30/202329,600 shares $74.59 thousand -0.3%0.2%2 $2.52 9/15/202329,700 shares $92.66 thousand -1.3%0.2%2.3 $3.12 8/31/202330,100 shares $108.66 thousand -30.0%0.2%1.4 $3.61 8/15/202343,000 shares $161.47 thousand +24.6%0.3%2.1 $3.76 7/31/202334,500 shares $148.70 thousand -20.0%0.2%1.6 $4.31 7/15/202343,100 shares $211.63 thousand -1.4%0.3%1.7 $4.91 6/30/202343,700 shares $228.99 thousand +7.1%0.3%1.6 $5.24 6/15/202340,800 shares $255.41 thousand +60.0%0.3%1.3 $6.26 5/31/202325,500 shares $157.59 thousand -37.4%0.2%0.8 $6.18 5/15/202340,700 shares $254.38 thousand +5.4%0.3%1.2 $6.25 4/30/202338,600 shares $188.37 thousand -14.2%0.3%1.1 $4.88 4/15/202345,000 shares $228.15 thousand +24.7%0.3%1.2 $5.07 3/31/202336,100 shares $171.11 thousand +71.9%0.2%1 $4.74 3/15/202321,000 shares $100.80 thousand +62.8%0.1%0.6 $4.80 2/28/202312,900 shares $72.50 thousand -6.5%0.1%0.5 $5.62 2/15/202313,800 shares $92.60 thousand -85.2%0.1%0.5 $6.71 1/31/202393,200 shares $706.46 thousand +162.5%1.0%3.3 $7.58 1/15/202335,500 shares $239.63 thousand -36.2%0.4%1.1 $6.75 12/30/202255,600 shares $299.13 thousand -27.8%0.6%1.8 $5.38 12/15/202277,000 shares $527.45 thousand -21.5%2.1%2.3 $6.85 11/30/202298,100 shares $657.27 thousand -11.1%1.6%3.1 $6.70 11/15/2022110,400 shares $734.16 thousand +69.1%1.8%3.7 $6.65 10/31/202265,300 shares $418.57 thousand -91.3%1.0%2 $6.41 10/15/2022749,700 shares $342.09 thousand +10.7%0.8%1.9 $0.46 9/30/2022677,300 shares $316.03 thousand -2.6%0.8%1.7 $0.47 9/15/2022695,500 shares $443.31 thousand +59.8%0.8%1.3 $0.64 8/31/2022435,200 shares $278.53 thousand -17.2%0.5%0.7 $0.64 8/15/2022525,600 shares $435.62 thousand +14.7%0.6%0.8 $0.83 7/31/2022458,400 shares $309.42 thousand -27.0%0.5%0.7 $0.68 7/15/2022628,100 shares $425.22 thousand -89.8%0.7%0.8 $0.68 6/30/20226,180,000 shares $3.80 million -25.5%7.3%7.9 $0.62 6/15/20228,290,000 shares $4.93 million No Change9.7%11 $0.59 5/31/20228,290,000 shares $4.73 million -0.5%9.7%10.2 $0.57 5/15/20228,330,000 shares $4.20 million +1.7%9.8%10.7 $0.50 4/30/20228,190,000 shares $4.59 million +15.2%9.4%9.9 $0.56 4/15/20227,110,000 shares $7.47 million -6.1%8.4%7.8 $1.05 3/31/20227,570,000 shares $9.08 million -1.3%8.9%6.9 $1.20 3/15/20227,670,000 shares $7.56 million +14.0%9.0%6.9 $0.99 2/28/20226,730,000 shares $5.48 million +1.2%7.9%5.7 $0.82 2/15/20226,650,000 shares $7.18 million -6.7%7.9%4.7 $1.08 1/31/20227,130,000 shares $8.70 million +4.9%8.5%4.5 $1.22 1/15/20226,800,000 shares $9.52 million +8.8%10.5%4.3 $1.40 12/31/20216,250,000 shares $10.94 million +1.3%9.7%4.3 $1.75 12/15/20216,170,000 shares $11.41 million No Change9.6%4.1 $1.85 11/30/20216,170,000 shares $10.80 million -6.5%9.6%3.5 $1.75 11/15/20216,600,000 shares $14.32 million -4.4%10.2%4.9 $2.17Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow 10/29/20216,900,000 shares $14.01 million -2.4%10.7%6 $2.03 10/15/20217,070,000 shares $15.91 million +1.1%10.9%7.1 $2.25 9/30/20216,990,000 shares $16.71 million +9.6%10.8%7.5 $2.39 9/15/20216,380,000 shares $16.78 million -2.6%9.9%6.8 $2.63 8/31/20216,550,000 shares $17.75 million -5.1%10.1%10.7 $2.71 8/13/20216,900,000 shares $18.35 million +0.7%10.7%9 $2.66 7/30/20216,850,000 shares $19.11 million +14.7%10.6%7.6 $2.79 7/15/20215,970,000 shares $18.03 million -10.2%9.2%6.6 $3.02 6/30/20216,650,000 shares $24.34 million +10.3%10.3%7.3 $3.66 6/15/20216,030,000 shares $24.30 million +3.6%9.3%5.9 $4.03 5/28/20215,820,000 shares $22.12 million No Change9.0%3.9 $3.80 5/14/20215,820,000 shares $25.84 million +3.4%N/A3.7 $4.44 4/30/20215,630,000 shares $29.16 million +0.9%N/A3.5 $5.18 4/15/20215,580,000 shares $29.57 million -1.1%N/A3.4 $5.30 3/31/20215,640,000 shares $30.68 million +67.4%N/A3.2 $5.44 3/15/20213,370,000 shares $32.08 million +22.6%N/A2 $9.52 2/26/20212,750,000 shares $22.03 million +23.9%N/A1.3 $8.01 2/12/20212,220,000 shares $17.58 million +4.7%N/A1.1 $7.92 1/29/20212,120,000 shares $13.50 million +2.9%N/A1.2 $6.37 1/15/20212,060,000 shares $13.31 million +0.5%N/A1 $6.46 12/31/20202,050,000 shares $15.97 million -16.3%N/A1.1 $7.79 12/15/20202,450,000 shares $11.74 million -23.7%N/A0.5 $4.79 11/30/20203,210,000 shares $10.21 million No Change10.8%0.8 $3.18 11/15/20203,210,000 shares $10.18 million -1.2%10.8%0.8 $3.17 10/30/20203,250,000 shares $11.08 million -11.4%14.3%0.8 $3.41 10/15/20203,670,000 shares $14.50 million +164.0%12.0%0.9 $3.95 9/30/20201,390,000 shares $2.82 million -11.5%4.5%0.4 $2.03 9/15/20201,570,000 shares $3.89 million -5.4%5.1%7.2 $2.48 8/31/20201,660,000 shares $3.97 million -8.8%5.4%6.7 $2.39 SLDB Short Interest - Frequently Asked Questions What is Solid Biosciences' current short interest? Short interest is the volume of Solid Biosciences shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 10,110,000 shares of SLDB short. 17.88% of Solid Biosciences' shares are currently sold short. Learn More on Solid Biosciences' current short interest. What is a good short interest ratio for Solid Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SLDB shares currently have a short interest ratio of 6.0. Learn More on Solid Biosciences's short interest ratio. Which institutional investors are shorting Solid Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Solid Biosciences: Group One Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Solid Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 17.88% of Solid Biosciences' floating shares are currently sold short. Is Solid Biosciences' short interest increasing or decreasing? Solid Biosciences saw a decrease in short interest during the month of July. As of July 31st, there was short interest totaling 10,110,000 shares, a decrease of 1.2% from the previous total of 10,230,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Solid Biosciences' float size? Solid Biosciences currently has issued a total of 77,869,000 shares. Some of Solid Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Solid Biosciences currently has a public float of 56,530,000 shares. How does Solid Biosciences' short interest compare to its competitors? 17.88% of Solid Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Solid Biosciences: Cidara Therapeutics, Inc. (10.92%), Dyne Therapeutics, Inc. (13.35%), Apogee Therapeutics Inc. (22.51%), Immunocore Holdings PLC Sponsored ADR (17.09%), Beam Therapeutics Inc. (25.22%), Twist Bioscience Corporation (17.83%), Travere Therapeutics, Inc. (12.44%), Aurinia Pharmaceuticals Inc (7.88%), WAVE Life Sciences Ltd. (13.29%), Edgewise Therapeutics, Inc. (13.20%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Solid Biosciences stock? Short selling SLDB is an investing strategy that aims to generate trading profit from Solid Biosciences as its price is falling. SLDB shares are trading down $0.33 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Solid Biosciences? A short squeeze for Solid Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SLDB, which in turn drives the price of the stock up even further. How often is Solid Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLDB, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies CDTX Short Interest DYN Short Interest APGE Short Interest IMCR Short Interest BEAM Short Interest TWST Short Interest TVTX Short Interest AUPH Short Interest WVE Short Interest EWTX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SLDB) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solid Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solid Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access